ULSC
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ULSC, covering 2025-01-24 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]